Technical analysis of The Travelers Companies, Inc. (TRV): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
The Travelers Companies, Inc., through its network of subsidiaries, delivers a broad spectrum of commercial and personal property and casualty insurance products and services. These offerings cater to businesses, government entities, associations, and individual clients both within the United States and internationally. The company's operations are divided into three primary segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance.
Price Performance
| 1 month | +9.95% |
| 3 months | +5.06% |
| Year-to-date | +36.60% |
| 1 year | +47.50% |
| 3 years | +135.27% |
| 5 years | +147.25% |
| 10 years | +278.54% |
52-Week Range
| 52-week High | $407.87 |
| 52-week Low | $264.25 |
| Avg Volume (90d) | 1.6M |
Technical Indicators
| SMA 50 | $374.58 |
| SMA 200 | $329.85 |
| Beta | 0.52 |
| 30-day Volatility (annualised) | 19.1% |
| Price vs SMA 50 | +5.8% |
| Price vs SMA 200 | +20.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $290.06 | |
| 2026-01 | $284.51 | -1.9% |
| 2026-02 | $308.64 | +8.5% |
| 2026-03 | $291.68 | -5.5% |
| 2026-04 | $305.14 | +4.6% |
| 2026-05 | $291.89 | -4.3% |
| 2026-06 | $330.12 | +13.1% |
| 2026-07 | $374.36 | +13.4% |
| 2026-08 | $365.93 | -2.3% |
| 2026-09 | $356.51 | -2.6% |
| 2026-10 | $396.22 | +11.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-01-20 | $9.88 | $10.72B |
| 2026-10-16 | $7.39 | $11.36B |
| 2026-07-17 | $5.41 | $11.26B |
| 2026-04-16 | $7.07 | $10.72B |
| 2026-01-21 | $8.80 | $11.12B |
| 2025-10-16 | $6.39 | $11.69B |
| 2025-07-17 | $3.65 | $11.62B |
Price
| Price | $396.22 (closing price, October 30, 2026) |
| Market Cap | $81.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 10.39 |
| Price / Book | 2.83 |
| Dividend Yield | 1.19% |
Financial Health
| Debt / Equity | 0.34 |
| Current Ratio | 1.32 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.06 |